MORTALITY AND DRUG ADDICTION François Hervé A.N.I.T. Glasgow 8 août 2005.

Slides:



Advertisements
Similar presentations
STREET OUTREACH. GOALS OF COURSE Identify who and what we are looking for. To identify techniques that can help in development of effective outreach.
Advertisements

The case study of Denmark Pernille Skipper Member of Parliament, Red Green Alliance.
New OST Clinical Guidelines in French prison setting L Michel, Centre Pierre Nicole, French Red-Cross O Maguet – C Calderon, CCMO Conseil.
Strategic, service provider and user responses to reducing fatal and non-fatal poisonings Rowan Williams, Development Manager, Drugaid.
Monitoring Trends in Illicit Drug Use in Australia Wayne Hall School of Population Health, University of Queensland and Louisa Degenhardt and Natasha Sindicich.
America’s biggest drug problem is the use of illicit “street” drugs.
Breaking the Taboo French Experience: One step forward, two steps backwards! Hans-Fredrik Gadelius Hôpital Nord Marseille Médecins du Monde CSAPA Nord.
Jennifer Hoolachan, PhD Candidate.  Youth literature focuses on recreational substance use  Homeless literature focuses on problematic substance use.
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
Do consumers of ecstasy-type pills take preventative measures to avoid bad effects from ecstasy-type pills? Dr Fairlie McIlwraith Associate Professor Rosa.
The Challenge of Opioid Addiction Valerie Valcour RN, Health District Director Carol Plante, Healthy Lamoille Valley * September 3, 2014.
Monitoring drug related overdose and mortality in Europe Dr. Eva Keller.
Killing the Pain: Prescription Drug Abuse and Other Risky Behaviors in Rural Appalachia Jennifer R. Havens, PhD, MPH Department of Behavioral Science Center.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
Drug Trends in Washington State & King County Caleb J. Banta-Green MPH MSW Alcohol & Drug Abuse Institute University of Washington
1 Description of the addiction service of the Republic of Uzbekistan Jur’at Umargaliev Ministry of Health.
Social Problems in the United States
National Research and Development Centre for Welfare and Health Knowledge for welfare and health1 Finnish Drug Treatment Information System Kristiina Kuussaari,
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Annual report 2010: the state of the drugs problem in Europe.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
OPIOID SUBSTITUTION THERAPY
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
Changes in drug policies in the Netherlands and their impact on drug markets Marianne van Ooyen-Houben Edward Kleemans ESC Porto September 2015.
Blattler et al (2002). Aim To investigate whether supplying heroin on a medical programme, combined with therapy, would reduce cocaine use among participants,
From the Monitoring the Future Study Report: The University of Michigan 2012.
Peter Sarosi Hungarian Civil Liberties Union (HCLU) Dialogoue on Drug Policy 8 June, European and Hungarian drug policies: based on evidence?
The United States is a drug culture. Americans use drugs on a regular basis to wake up in the morning (coffee and tea), get through the day (cigarettes),
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
STRATEGY OF DRUG AND HIV/AIDS PREVENTION IN THE CITY AND DISTRICTS OF TALLINN Ene Tomberg Department of Social Welfare and Health Care of Tallinn.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Lexington High School Youth Risk Behavior Survey Results Ten Year Trends.
The “Sastipen Network Information System” Facing Drugs within the Roma Community: Gathering of Information for the development of indicators “The Sastipen.
Historical Mapping of HIV Programmes 1985 – 2012 in Malawi Presented at the 20 TH INTERNATIONAL AIDS CONFERENCE, MELBOURNE, AUSTRALIA 24 th July 2014 By.
Role of harm reduction in HCV prevention in France: from research to scale up Bruno Spire & Patrizia Carrieri.
Better health for individuals What does health mean to individuals.
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
Scottish Drugs Forum Glasgow 30th June 2005 Residential Drug Services – Where do they fit on the treatment map? The situation in Switzerland Nicolas Heller.
HIV/AIDS, Housing and Risk Behaviors CT AIDS Resource Coalition and CIRA Community Research Partnership Program.
Decline in incidence of HIV and Hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? 1. Julius Center, University.
Neil Hunter Community Services Manager – Glasgow Addiction Service Strategic approach to drug deaths.
Jennifer R. Havens, PhD, MPH Associate Professor
Evaluating screening and brief intervention in a criminal justice setting Adrian Barton & Greta Squire School of Law and Social Science University of Plymouth.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS State of the art and new perspectives in drug addiction treatment Dr L Michel, MD, PhD Inserm U1178.
BULGARIAN NATIONAL STRATEGY FOR COMBATING DRUG ABUSE Reporter: Yuri Katsarov /01 – 02 October 2015/ City of Reykjavik Promoting the bilateral.
1 READY BY 21 TASKFORCE Harford County Department of Community Services Local Management Board Health Benchmark December 7, 2010.
HIV in India David S. Hausner American Embassy School 8 th Grade Population Project 24 February 2012.
Peculiarities of alcoholism prevalence in Russia and measures to reduce alcohol abuse Eugenia A. Koshkina Director, National Research Center on Addictions,
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
Substance Abuse By: Joe Gonzalez & Danielle Lyner.
Drug-related deaths Phil Conley Health Improvement Programme Manager September 2015.
The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
The Highs and Lows of Relapse and Recovery in Opioid Use Disorder
6% of adults had used one or more illicit drugs in last 12 months.
COCAINE.
Medication-Assisted Therapy at Coleman Profession Services
COLLECTIVE IMPACT APPROACH TO ADDRESSING
The Efficacy of RN Supervised Safe Injection Sites
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
The European Experience: Prescription Drug Misuse in France, Germany, Italy and Spain 24 October 2017 Presented at Lisbon Addictions 2017 Jody L. Green,
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Causes of Drug Related Death
Pain Management and Substance Use Disorders: JCPP Strategic Session
German Drug and Addiction Policy
Substance Use Prevention for Young Adults and Higher Education
Human Dignity and Harm Reduction
Presentation transcript:

MORTALITY AND DRUG ADDICTION François Hervé A.N.I.T. Glasgow 8 août 2005

What are the facts? In the eighties, increase of the mortality In the eighties, increase of the mortality –Overdoses –Aids –By the time treatments where mainly Withdrowal (only 50 people in France in methadone programs) Withdrowal (only 50 people in France in methadone programs) Psychosociological treatments in rehabilitation facilities Psychosociological treatments in rehabilitation facilities No much consideration for the health of the patients, beside addiction No much consideration for the health of the patients, beside addiction

Time for debates End of the eighties End of the eighties –Debates about harm reduction Interest for foreign models Interest for foreign models –Switzerland (4 pillars: prevention, treatment, harm reduction, repression) –Nederland (organisations of drug users) –England (involvement of gp’s) Needle exchange Needle exchange Methadone and substitution Methadone and substitution  1988: free access to serynges at chemists

Time for action: new policies Early nineties: Early nineties: –Beginning of harm reduction strategies Methadone (1994) Methadone (1994) Buprenorphine (subutex®)(1996) Buprenorphine (subutex®)(1996) –Harm reduction facilities Needle exchange Needle exchange Street work Street work

EFFECTS ON THE NUMBER OF DEATH

EVOLUTION OF DEATHS BY OD

Number of deaths due to aids among injecting drug users *2002*2003* * données redressées Nombre de décès UDVI UDVI = usagers de drogue par voie injectable Apparition of treatments Better acces to treatments ? 24% of the deaths due to aids

New cases of Aids among drug users *2002*2003* * données redressées UDVI= usagers de drogues par voie injectable Harm reduction 30% of the new contaminations 2,8% of the new contaminations

Development of the substitution treatments

MéthadoneBuprénorphine Initial prescriptionSpecialised centers, hospitals (possibility to hand over to gp’s after stabilisation of the treatment)) Any doctor (91 to 99% of the prescriptions) Duration maxi of prescription 14 days28 days Délivery1 to 7 days (possibility until 14 days if mentionned) 7 days (possibility until 28 days if mentionned by the doctor) Fractionnement (splitting up) ouioui Chevauchement (overlapping) if mentioned by the doctor Renouvellement (renewal) forbiden Rules for presciption

CONCLUSION PART 1 Good results The number of deaths by overdoses registred by the police decreases since 1995, after a maximum (564) in 1994, 89 deaths in The number of deaths by overdoses registred by the police decreases since 1995, after a maximum (564) in 1994, 89 deaths in In 2003, héroïne is still the drug the most often involved in death by OD (39 % of the cases) but the part of heroine decreases regularly (90% in 1993 and 1994) In 2003, héroïne is still the drug the most often involved in death by OD (39 % of the cases) but the part of heroine decreases regularly (90% in 1993 and 1994) An increasing proportion of deaths involves the use of medecine drugs, including méthadone and Subutex®, (31 % en 2003,15 % en 1995). An increasing proportion of deaths involves the use of medecine drugs, including méthadone and Subutex®, (31 % en 2003,15 % en 1995). The number of overdoses due to cocaïne and ecstasy is also increasing (11 et 10 % in 2003 against less than 1 % in 1995 for cocaïne and 7,5 % in 2001 for ecstasy). The number of overdoses due to cocaïne and ecstasy is also increasing (11 et 10 % in 2003 against less than 1 % in 1995 for cocaïne and 7,5 % in 2001 for ecstasy).

Discussion: Some hypotheses –Less interest of the users for heroin, since the avability of substitution treatments since the avability of substitution treatments because a bad image of heroin and injection because a bad image of heroin and injection –Less injections –Better knowledge of the treatment of OD by the emergengy medical units, and by the users. –The important rise of overdoses in the late 80ies early 90ies could be due to the context: aids, number of dying people, lack of treatments, leading to more self destructive behaviors: the treatments of aids may have had more incidence on the diminution of deaths than the substitution treatments.

CONCLUSION PART 1 New problems: Trafic: 6 to 10% of the users divert 25% of the treatments  black market Trafic: 6 to 10% of the users divert 25% of the treatments  black market –6% of the individuals receiving a prescription over a 6 month period carry on a significant traffickng activity: they receive more than 32 mg of HDB per day (51 mg on average) (CNAMTS) The average daily treatment is 9.6mg. On this basis: The average daily treatment is 9.6mg. On this basis: –Patients really engaged in long term treatment: –Patients receiving precriptions on an irregular basis: about –Users of buprenorphine without precription: at least 4000 Misuse : Misuse : –injecting, 11% in medical protocols, 54% for those who expect a product for getting « high » –sniffing, Starting addiction with subutex® Starting addiction with subutex®  important to know more about the behavior of the users  No incidence on the number of drug users

Evolution since 1992 of drug use, among years old population %

Overmortality according to product involved in the arrest substanceMenWomen smrsmr Individuals arrested for héroin/cocaine/crack use 5,19***9,52*** Heroin5,27***9,74*** Cocaine4,31***8,50*** Crack4,50***5,39 French population as a whole 1,01,0 ***:=p<0,001 Reading: men arrested for heroin cocaine crack use have a risk of dying 5,19 times higher than men of the same age in the french population

Fighting drug related deaths: Knowing more about addictions Importance to have a good knowledge of: Importance to have a good knowledge of: –The new drugs arriving on the market –Their diffusion –The new ways to use them –The expectations and behaviors of the users

Two Main systems of observation –TREND (tendances récentes et nouvelles drogues) (New tendancies and new drugs) –SINTES (Système d’identification national des toxiques et des substances)(National System of identification of toxics and substances)

TREND Objectives: Objectives: –Give to the policy makers, professionnals and drug users some elements of knowledge able to modify their decisions or their practice Means: Means: –A network of several sites collecting informations –Continue collect and analysis –Annual report

TREND 2 Combination of differents tools: Combination of differents tools: –Focal groups –Ethnographic observations –Qualitatives questionnaries –Quantitatives enquiries (in low threshold facilities) –Interviews of ressource people –Interviews of users

TREND 3 Who collects the data? Who collects the data? –Drug Users –Ethnographic professionnals –Members of the teams from harm reduction actions –Teams involved in harm reduction on the techno scene –Medical teams –police

TREND 4 Data collected: Data collected: –Characterics of users –Ways to use drugs –Social and health damages –Perception of the drugs –Ways to get drugs –New populations of users –Treatment of the information about drug by the media (press)

SINTES (Système National d’Identification des Toxiques et des Substances) Objectives: Objectives: –identify new tendencies or new drugs (identification of new molecules or new association of molecules, by the mean of analysis of synthetic drugs) Methodology: Methodology: –Continue Collect of the drug by a network of actors (involved in prevention, harm reduction…) –Files coming from the laboratories of the police and the customs

sintes

SINTES (Système National d’Identification des Toxiques et des Substances) Diffusion of information : N+1week Diffusion of information : N+1week Annual report Annual report

Conclusion 564  89 death (at least…) What had an impact on drug related deaths?

To be as near as possible of the drug users, when and where they use drugs To be as near as possible of the drug users, when and where they use drugs More consideration for their health More consideration for their health A better knowledge of behaviors and substances A better knowledge of behaviors and substances A better communication betwen policy makers, professionnals, and drug users A better communication betwen policy makers, professionnals, and drug users

BUT

Have we solved the addictions problems with new policies?

No. We just change it.